资讯|论坛|病例

搜索

首页 医学论坛 专业文章 医学进展 签约作者 病例中心 快问诊所 爱医培训 医学考试 在线题库 医学会议

您所在的位置:首页 > 肿瘤科诊疗指南 > 2009CCO/PET成像用于胰腺癌诊断

2009CCO/PET成像用于胰腺癌诊断

2014-05-23 15:57 阅读:2506 来源:爱爱医 责任编辑:张子玲
[导读] In some cases where sufficient evidence existed, meta-**yses were included withpooled likelihood ratios.

    《2009CCO/PET成像用于胰腺癌诊断》内容简介:

    In some cases where sufficient evidence existed, meta-**yses were included withpooled likelihood ratios. The AHRQ review included evidence tables that summarized thecharacteristics and results of each study according to the outcomes the study addressed. Fordiagnostic performance, the evidence tables recorded details on the source of the publicationand the evidence grade, study design, patient characteristics, PET technical characteristics,criteria for interpretation, and results.

    《2009CCO/PET成像用于胰腺癌诊断》内容预览:

   
Provincial Consensus Process

    The consensus meeting on 25 November 2008 was conducted as follows:

    Presentations by each of the clinical lead authors on the DRAFT DSG recommendations

    and supporting evidence were made to the meeting participants.

    The recommendations were refined by the large group, and in some cases a revised

    recommendation was proposed, resulting in a FINAL recommendation.

    The participants voted on the FINAL recommendations to indicate their extent of

    agreement on a scale from 1 to 7 (1 indicating strong agreement, 5 indicating no

    agreement or disagreement, and 7 indicating strong disagreement)。

    RESULTS

    Literature Search Results

    The AHRQ review results for pancreatic cancer included 17 primary studies. Data from

    the evidence tables are summarized in Appendix 1. In addition to data for diagnostic

    performance, summaries of results for diagnostic thinking and management strategy are also

    presented where they apply. The key evidence is described below in an abbreviated fashion.

    Key Evidence

    Diagnosis/Staging

    Eleven prospective studies were identified that evaluated the role of PET or PET/CT in the

    diagnosis of a suspicious pancreatic mass. Sensitivity ranged from 69% to 97%, and

    specificity ranged from 61% to 97% (Giorgi2004 [3], Nishiyama2005-100 [4], Rasmussen2004

    [5], van Kouwen2005 [6], Bang2006 [7], Heinrich2005 [8], Lemke2004 [9], Lytras2005 [10],

    Maemura2006 [11], Sperti2007 [12], Casneuf2007 [13])。


    点击下载***:《2009CCO/PET成像用于胰腺癌诊断》


分享到:
  版权声明:

  本站所注明来源为"爱爱医"的文章,版权归作者与本站共同所有,非经授权不得转载。

  本站所有转载文章系出于传递更多信息之目的,且明确注明来源和作者,不希望被转载的媒体或个人可与我们

  联系zlzs@120.net,我们将立即进行删除处理

意见反馈 关于我们 隐私保护 版权声明 友情链接 联系我们

Copyright 2002-2025 Iiyi.Com All Rights Reserved